MARKET

CAPR

CAPR

Capricor
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.080
-0.010
-0.32%
Closed 16:00 09/23 EDT
OPEN
3.140
PREV CLOSE
3.090
HIGH
3.160
LOW
2.952
VOLUME
106.76K
TURNOVER
--
52 WEEK HIGH
11.50
52 WEEK LOW
2.300
MARKET CAP
11.51M
P/E (TTM)
-0.8195
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CAPR and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CAPR News

  • Bruker (BRKR) Enters Into Alliance With Murdoch University
  • Zacks.5h ago
  • Did You Manage To Avoid Capricor Therapeutics's (NASDAQ:CAPR) Devastating 92% Share Price Drop?
  • Simply Wall St..2d ago
  • Neogen Forms Partnership With IGS to Enhance Beef Profile
  • Zacks.3d ago
  • Medtronic Receives European Nod for Glucose Monitoring System
  • Zacks.4d ago

More

Industry

Biotechnology & Medical Research
-0.69%
Pharmaceuticals & Medical Research
-0.43%

Hot Stocks

Name
Price
%Change

About CAPR

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapeutics. The Company focuses on discovering, developing and commercializing regenerative medicine and large molecule products for the treatment of disease, with a primary focus on the treatment of cardiovascular diseases, including orphan indications. Its product candidate, CAP-1002, a cardiosphere-derived cell product, is being tested in the ALLSTAR Phase II clinical study on patients having suffered a myocardial infarction (MI), while the DYNAMIC clinical study is testing CAP-1002 in patients in the advanced-stage of heart failure. CAP-1002 is also being tested in the HOPE-Duchenne Phase I/II clinical study for use in connection with Duchenne muscular dystrophy-related cardiomyopathy. Cenderitide, a dual receptor natriuretic peptide agonist, is being tested in a Phase II clinical study. Exosomes are nano-sized, membrane-enclosed vesicles.
More

Webull offers Capricor Therapeutics Inc (CAPR) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.